Successful Virtual Necropsy and Specimen Study Logistics, Upcoming Webinar Hosted by Xtalks
TORONTO, Jan. 14, 2022 /PRNewswire-PRWeb/ -- Join this webinar to learn StageBio's four best practices for a successful virtual necropsy — and save resources and time doing it. This webinar will benefit those working with pathologists virtually and provide tips on how to maximize a study process while reducing research timelines.
This webinar will also review how courier/archiving services can support a study and benefit research. StageBio provides necropsy support and courier/archiving logistics services. StageBio invites webinar registrants to contact them with any questions they have in advance, and StageBio will be sure to address them in the webinar.
Join StageBio's Senior Pathogists Dr. David Garlick and Dr. Laura Elcock; and Vice President of General Histology and Archiving Services Sam Jeffrey for the live webinar on Tuesday, February 1, 2022 at 1pm EST.
For more information, or to register for this event, visit Successful Virtual Necropsy and Specimen Study Logistics.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Sydney Perelmutter, Xtalks, +1 (416) 977-6555 x 352, firstname.lastname@example.org
Upcoming Life Sciences Events
- June 2023
- Boston: Product & Company Valuation Course
- BIO International Convention 2023
- RESI Boston
Latest company news
Asep Inc. Announces Ground-breaking A.I. Technology for Rapid Identification of Severe Sepsis and Improved Superbug Therapies
Jazz Pharmaceuticals and Zymeworks Present Positive Pivotal Phase 2b Trial Data at ASCO 2023 Evaluating Zanidatamab in HER2-Amplified Biliary Tract Cancers
Certara to Participate in the Jefferies Global Healthcare Conference